{"result_id": "265044", "URL": "https://sanevax.org/research-blog/gardasil-silgard-vaccine/", "timestamp": "2023-04-25 17:02:53 CEST+0200", "meta": {"description": "", "lang": "en", "keywords": "", "favicon": "https://sanevax.org/wp-content/themes/lifestyle-pro-elf/images/favicon.ico", "canonical": "https://sanevax.org/research-blog/gardasil-silgard-vaccine/", "encoding": "UTF-8"}, "image": null, "domain": "sanevax.org", "title": "Gardasil/Silgard Vaccine Archives", "cleaned_text": "Authors: Diane M. Harper and Karen B. Williams Abstract: Approaches for cervical cancer prevention are changing. Screening still remains the most effective method for cervical cancer prevention. Guidelines are moving to an older group of women to be screened less frequently with combinations of technologies that include biomarkers and cytology. HPV vaccination is an appropriate option for [\u2026]", "opengraph": {"locale": "en_US", "type": "article", "title": "Gardasil/Silgard Vaccine Archives - SaneVax, Inc.", "url": "https://sanevax.org/research-blog/gardasil-silgard-vaccine/", "site_name": "SaneVax, Inc."}, "tags": ["CNS disorders", "lobbying", "efficacy", "HPV VACCINES", "clinical trials", "duration of efficacy", "policymaking", "cervical cancer prevention", "HPV vaccination", "Denmark", "cervical cancer screening", "HPV vaccine", "legislation", "cervarix", "HPV vaccine efficacy", "Gardasil", "human papillomavirus"], "tweets": [], "movies": [], "links": ["https://sanevax.org/prophylactic-hpv-vaccines-impact-on-premalignancies/"], "authors": [], "publish_date": "January 22, 2020"}